Interestingly, but not surprisingly, it has been highlighted that SFN can strongly inhibit the NF-κB signaling pathway in breast carcinoma cells and considerably attenuates 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced Matrix metalloproteases (MMP-9) expression thereof. The gene discussed is NFKB1; the disease is breast carcinoma.